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Aims    To develop a computer processable algorithm, capable of running automated searches of 
routine data that flag miscoded and misclassified cases of diabetes for subsequent clinical review.  
Method    Anonymized computer data from the Quality Improvement in Chronic Kidney Disease 
(QICKD) trial (n = 942 031) were analysed using a binary method to assess the accuracy of data on 
diabetes diagnosis. Diagnostic codes were processed and stratified into: definite, probable and possible 
diagnosis of Type 1 or Type 2 diabetes. Diagnostic accuracy was improved by using prescription 
compatibility and temporally sequenced anthropomorphic and biochemical data. Bayesian false 
detection rate analysis was used to compare findings with those of an entirely independent and more 
complex manual sort of the first round QICKD study data (n = 760 588). 
Results    The prevalence of definite diagnosis of Type 1 diabetes and Type 2 diabetes were 0.32% and 
3.27% respectively when using the binary search method. Up to 35% of Type 1 diabetes and 0.1% of 
Type 2 diabetes were miscoded or misclassified on the basis of age/BMI and coding. False detection 
rate analysis demonstrated a close correlation between the new method and the published hand-crafted 
sort. Both methods had the highest false detection rate values when coding, therapeutic, 
anthropomorphic and biochemical filters were used (up to 90% for the new and 75% for the hand-
crafted search method).  
Conclusions    A simple computerized algorithm achieves very similar results to more complex search 
strategies to identify miscoded and misclassified cases of both Type 1 diabetes and Type 2 diabetes. It 
has the potential to be used as an automated audit instrument to improve quality of diabetes diagnosis.  
Keywords    diabetes mellitus, diagnostic errors, computerized medical informatics, medical records 
systems. 
  
Introduction 
Primary care records are largely computerised with most primary care clinicians entering data at the 
point of care. Electronic patient records facilitate improved management of chronic diseases including 
diabetes [1]. However, a combination of factors may reduce data quality, including: time pressures that 
limit what is recorded in the electronic patient record; changes in diagnostic criteria and classification 
rules for diabetes [2]; sampling labelling problems (it may not be obvious if a sample is fasted) [3]; and 
idiosyncrasy in the coding interface. Furthermore, the various brands of EPR offer different coding 
choices for the same search term [4]. 
We have demonstrated that a pragmatic search strategy can identify classification problems in 
diabetes. Many people labelled as having Type 1 diabetes (Type 1 diabetes) are misclassified and 
actually have Type 2 diabetes mellitus (Type 2 diabetes) and some with Type 2 diabetes may not have 
diabetes at all [5]. Coding of diabetes diagnostic data is both complex [6] and in need of refinement 
[5,7] and current practice probably overestimates the prevalence of diabetes [5]. Recognition of these 
gaps has led NHS Diabetes [8] and the Royal College of General Practitioners (RCGP) to launch ‘The 
Classification of Diabetes’ initiative [9]. 
The pragmatic method of identifying classification errors cannot easily be converted into code that 
can be processed by existing electronic patient record systems to automatically identify errors and flag 
patients for review. The pragmatic method can be used as an audit method, but is labour intensive and 
clinician time is at a premium. We therefore set out to develop a binary method that would allow 
automatic identification of misclassified cases for subsequent clinical review. 
Methods 
We used two datasets from the Quality Improvement in Chronic Kidney Disease (QICKD) trial [10]. 
The QICKD study is being conducted in 129 practices drawn from localities across England. It is 
intended to have a population profile to match the National average, although it has a slight excess of 
working-age people and slightly fewer older people aged 60–75 years. The standardized prevalence of 
diabetes within the study cohort is 4.0% [11]. The first dataset was collected at baseline and the second 
set of data was collected approximately 1 year later. There was no change in diabetes prevalence 
between these collection points. Although these data were extracted for a cluster randomized trial they 
are from ordinary general practices taking part in a quality improvement trial in chronic kidney disease, 
and should reflect standard routinely collected primary care data. 
We designed and tested a simple structured search engine employing Boolean logic, which might be 
used to improve data quality and highlight cases requiring further investigation [5]. We used a simple 
binary algorithm to sort diagnostic codes into definite, probable or possible Type 1 diabetes or Type 2 
diabetes based on the specificity of the diagnostic term. In addition we identified whether there were 
and contradictory codes, (e.g. classified as both Type 1 diabetes and Type 2 diabetes; see the 
Supporting Information). We then applied filters based on the NHS Diabetes/RCGP algorithm [9,12]. 
We explored compatibility of insulin and/or oral anti-diabetic drugs were compatible with the 
particular type of diabetes. We next explored whether age and BMI suggested a classification error.  
Using established methods, variables were exported into a flat file, one line per anonymized patient 
record and one column per variable [13,14]. Our initial sorting strategy grouped people into definite 
Type 1 diabetes or Type 2 diabetes where they had at least two specific diagnostic codes (in the UK 
Read codes C10E for Type 1 diabetes and C10F for Type 2 diabetes) over a 4-year period in the 
absence of any contradictory codes.  
Where people had specific codes for Type 1 diabetes or Type 2 diabetes we used binary code to 
represent the presence or absence of a definite diagnosis in each of the last four years. We then 
compared the last four years’ data for Type 2 diabetes with the same four years’ Type 1 diabetes data. 
To qualify as a definite diagnosis it was necessary to have a minimum of two specific (or first rank) 
codes for that type of diabetes with no contradictory codes; ‘“1’ represented the presence of and ‘0’ the 
absence of a definite diagnosis during each of these four years. We represented the data as two separate 
series of four binary numbers, the first four representing the presence or absence of a definite code for 
Type 2 diabetes over the last four years and the second group for Type 1 diabetes. For example, a 
person who had two definite codes for Type 1 diabetes might be represented by 0000–0011 and a 
person with two definite codes for Type 2 diabetes by 1100–0000. The possible combinations are set 
out in the Supporting Information.  
We used a similar binary sort process to identify a probable diagnosis of a given type of diabetes. A 
probable diagnosis was defined when a case had at least three identical positive codes for one type of 
diabetes and no more than one contradictory code for the other type over the four 1-year periods. Again 
  
we placed the four years’ binary codes for Type 2 diabetes together, followed by the same four years’ 
data for Type 1 diabetes. We sorted Type 2 diabetes data first because the prevalence of Type 2 
diabetes is much more common than Type 1 diabetes. For example, 0001–1101 represents a probable 
diagnosis of Type 1 diabetes because there is only one Type 2 diabetes code in the 4-year period but 
three Type 1 diabetes codes in the second period; in contrast 1110–1000 represents a probable 
diagnosis of Type 2 diabetes. 
We defined a possible diagnosis when there were two or more contradictory codes (e.g. 0011–1111 
for possible diagnosis of Type 1 diabetes and 1111–1001 for possible diagnosis of Type 2 diabetes).  
We developed a further sort mechanism for those who had diabetes diagnostic codes that did not 
map to either Type 1 diabetes or Type 2 diabetes; generally diagnostic labels associated with the out-
of-date classification of diabetes [15] for example C108 ‘Insulin dependent diabetes’ and C109 ‘Non-
insulin dependent diabetes’. This was a two-step process. First, we linked less specific codes to a 
plausible type of diabetes (generally insulin dependent to Type 1 diabetes and non-insulin dependent or 
‘maturity onset’ to Type 2 diabetes). We then used our filters to check whether therapy, BMI and age 
were compatible with this initial sort. We termed these less specific codes ‘second rank’ codes 
(Supporting Information, Table S1). We performed this search using data from any three of our four 
time-points; again presenting binary code for three Type 2 diabetes data points in front of those for 
Type 1 diabetes. A probable diagnosis would be made if there were two more identical codes in the 
absence of a contradictory diagnosis (i.e. 000–110; probable Type 1 diabetes or 110–000; probable 
Type 2 diabetes). In addition a possible Type 1 diabetes or Type 2 diabetes diagnosis would be made if 
three identical specific codes were recorded over the three time-points in the presence of a single 
contradictory code (i.e. 100–111, possible Type 1 diabetes, or 111–100, possible Type 2 diabetes).  
The filters were also created using four time-points and coded in a binary format. The therapeutic 
filter using binary code was then generated to differentiate people on insulin, metformin or other oral 
anti-diabetic medication from 2005 to 2008. We classified people using the four data points identifying 
prescriptions of insulin, metformin or oral anti-diabetic medications one or more times in any of the 
years. For example, 0000–0011–0000 represents a patient not on insulin but prescribed metformin in 
2007/8 in the absence of another OAD. A final filter using BMI and age was used to further 
differentiate between putative cases of Type 1 diabetes and Type 2 diabetes. The filter was applied at 
the earliest point of a diagnosis and the cut-offs for age and BMI were 35 years of age and 30kg/m2 
respectively.  
All binary code and filter data were then extracted and recoded into SPSSTM syntax (Supporting 
Information, Figure S1) and a search of the database was created to classify all definite, probable and 
possible cases of Type 1 diabetes and Type 2 diabetes taking into account their therapeutic, 
anthropomorphic and biochemical data. Subjects with incomplete datasets (i.e. missing values for 
diagnostic codes, age, therapeutic data or biochemical results) could not be included in the analysis.  
We used Bayesian statistics to test the new method compared with the previously published 
approach [5]. The false discovery rate [16] control, an exploratory statistical analytical method to 
control rigorously [17] the expected proportion of type I errors (i.e. rejected null hypothesis), was used 
to compare findings. The analysis was stratified into three levels: level 1 entailed false discovery rate 
analysis on the basis of coding alone, level 2 on the basis of coding and therapeutic data and level 3 on 
the basis of levels 1 and 2 and anthropomorphic and biochemical data. We then compared false 
discovery rates between the two search methods. 
Results 
The data used for this study were follow-up data (n = 942 031) from the QICKD study, compared with 
first set of data (n = 760,588) that were sorted using the complex manual method. 
The prevalence, in the Round 2 study data, of definite Type 1 diabetes and Type 2 diabetes were 
0.32% and 3.27%, respectively (Table 1). Non-definitive (i.e. probable and possible) diagnostic codes 
accounted for fewer than 8% of all diagnoses of diabetes (Figure 1). Specific diagnostic coding 
identified 94% and 98% of Type 1 diabetes and Type 2 diabetes, respectively. Of the definite Type 1 
diabetes diagnoses 31% (1004) had contradictory therapeutic data, and of those over 99% did not meet 
BMI/age criteria thought to be characteristic of people with Type 1 diabetes (Figure 1). Similarly, of 
the probable and possible Type 1 diabetes diagnoses 77% and 61% were also misclassified respectively 
on the basis of BMI/age criteria. Overall 35% of all Type 1 diabetes diagnoses were misclassified 
(Figure 1A), and nearly all should have been classified as Type 2 diabetes. Of all Type 2 diabetes 
diagnoses (n = 31,438) only 0.1% (n = 35) were misclassified on the basis of BMI/age at the earliest 
point of diagnosis (Figure 1). 
 
  
We had to exclude 488 people, under 1.5% of the subjects with diabetes, from the study because we 
did not have enough data to sort them. This group comprised 37 with codes suggestive of steroid-
induced diabetes, 46 with a possible Type 1 diabetes code; 161 with a possible Type 2 diabetes and 244 
with a code that did not imply either Type 1 diabetes or Type 2 diabetes.  
False discovery rate control analysis demonstrated a close correlation between the algorithmic 
binary search method and the independent search method in correctly identifying misclassified diabetes 
(Type 1 diabetes and Type 2 diabetes). At increasing levels of false discovery rate analysis for Type 1 
diabetes a similar increase was noted in both the ability of the binary and independent sort methods in 
identifying false positives (i.e. incorrectly labelled as misclassified) (Table S1). The use of definitive 
diagnostic Type 1 diabetes coding alone (level 1 false discovery rate] only highlighted 5% (false 
discovery rate 0.05) and 3% (false discovery rate 0.03) of false positives using the binary and 
independent search methods respectively. The false discovery rate was highest at Level 3 (a summation 
of coding, therapeutic, anthropomorphic and biochemical filters for Type 1 diabetes) with 90% (false 
discovery rate0.897) and 75% (false discovery rate 0.75) for the binary and independent search 
methods respectively. 
Comparative analysis of the Level 1 false discovery rate values for Type 2 diabetes, although low 
overall, demonstrated a threefold difference between the manual (false discovery rate 0.06) and binary 
search (false discovery rate 0.02) method. Level 2 false discovery rate analysis (i.e. therapeutic coding) 
could not be performed, as therapy was not used in the search strategy of Type 2 diabetes.  
Conclusion 
A simple binary computer processable algorithm with high false discovery rate values can accurately 
identify misclassified and misdiagnosed cases of both Type 1 diabetes and Type 2 diabetes. The binary 
algorithm demonstrated combined prevalence for Type 1 diabetes and Type 2 diabetes similar to those 
highlighted in a recent study using the QICKD (n = 250,000) and CONDUIT (n = 750,000) data sets 
[5].  
The binary algorithm confirms that current diabetes coding practice may overestimate the 
prevalence of diabetes overall and in particular Type 1 diabetes [5]. Over 30% of Type 1 diabetes were 
noted to be misclassified and probably have a diagnosis of Type 2 diabetes (Figure 1).  
A major limitation of the study is that we could not reliably process plasma glucose data, as fasting 
status is often not recorded [3]. We could, however, have included plasma glucose values above 
11.0 mmol/l on at least two occasions or used HbA1c (≥ 6.5%, 48mmol/mol) [18]. These variables 
could be tested to assess their discriminatory power and then added to later refinements of the sorting 
tool. Any final toolkit for clinical use could also detect those with medications exclusively used to treat 
diabetes and hyperglycaemia. There remained a small number cases, < 1.5% of people with diabetes, 
who may require a manual review of their records to confirm their type of diabetes. 
Problems with diagnostic diagnosis are not limited to diabetes; we have also found issues in chronic 
kidney disease [19], heart failure [20], osteoporosis [21] and chronic obstructive pulmonary disease 
[22]. Although piloted in primary care this approach could be used in any setting where diagnostic 
codes, therapy, age and BMI are available. This strategy could also be implemented routinely before 
referral to a specialist or for screening procedures, such as retinopathy screening, to check the accuracy 
of diagnostic data.While automated testing for coding errors is feasible, further testing is recommended 
before national adoption. We are close to the point where errors in the classification of diabetes might 
be detected automatically. 
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Supporting Information 
Additional Supporting Information may be found in the online version of this article. 
Figure S1. Extraction and binary recoding of data in SPSS. 
Table S1. Binary coding for 1st rank codes and 2nd ranks codes illustrating diagnostic levels on the 
basis of temporal sequencing of first registered diagnosis in each year from 2005 to 2008.  
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting 
materials supplied by the authors. Any queries (other than missing material) should be directed to the 
corresponding author for the article. 
  
FIGURE 1 
Binary algorithmic stratification of the diagnosis of diabetes using diagnostic codes and secondary filters. 
Classification and misclassification of Type 1 diabetes (left) and Type 2 diabetes (right) on the basis of specific 
and non-specific diagnostic codes with quality filtering using therapeutic, anthropomorphic and biochemical data. 
Data in italics are from the pragmatic independent search method. 
 
TABLE 1 
Comparative analysis of prevalence and false detection data for the binary and independent sort method. Upper: 
prevalence and combined sex prevalence of Type 1 diabetes  and Type 2 diabetes  for the chronic kidney disease 
dataset using the binary machine processable algorithm compared with data from the Quality Improvement in 
Chronic Kidney Disease (QICKD) (n = 760 588). Lower: comparative false detection rate analysis using the 
binary and independent sort methods for Type 1 diabetes 
 Binary algorithm 
(N = 942,031) 
Independent sort method 
(N = 760 588) 
Prevalence 
Type 1 diabetes % (n) 0.32 (3034) 0.35 (2662) 
Type 2 diabetes % (n) 3.27 (30839) 3.9 (29 663) 
False detection rate analysis search filter for Type 1 diabetes 
Level 1 (definitive codes) 0.05 0.03 
Level 2 (Definitive codes + therapeutic data) 0.35 0.28 
Level 3 (Definitive codes + therapeutic 
data + anthropomorphic + biochemical data) 0.897 0.75 
 
 
  
 
Figure 1: Binary algorithmic stratification of the diagnosis of diabetes using diagnostic codes and 
secondary filters….. 
 
 
